Related Experiment Video
Updated: Aug 5, 2026
04:03
Application of Laparoscopic Ultrasonography in Primary Choledochal Suture during Combined Two-lens Surgery
Published on: March 28, 2025
Bioavailability of medication after laparoscopic cholecystectomy
A B Elfant1, S M Levine, B Cencora
1Division of Gastroenterology, UMDNJ-Robert Wood Johnson Medical School at Camden, USA.
Journal of Laparoendoscopic Surgery
|August 1, 1995
Summary
Post-laparoscopic cholecystectomy, oral acetaminophen bioavailability is reduced for up to 12 hours. Medication should be used cautiously during this period to ensure patient safety and effective treatment.
Area of Science:
- Pharmacokinetics
- Gastroenterology
- Surgical Recovery
Background:
- Limited data exists on oral medication bioavailability after laparoscopic cholecystectomy.
- Concerns regarding postoperative oral drug tolerance and discharge timing are prevalent.
Purpose of the Study:
- To investigate the impact of laparoscopic cholecystectomy on acetaminophen bioavailability.
- To determine the optimal timing for oral medication administration post-surgery.
Main Methods:
- Prospective study involving 3 groups receiving acetaminophen (20 mg/kg) preoperatively.
- Repeat dosing at 6, 12, or 24 hours postoperatively.
- Serum acetaminophen levels measured at 40 and 90 minutes post-ingestion.
Main Results:
- Significantly decreased acetaminophen bioavailability observed at 6 and 12 hours post-laparoscopic cholecystectomy (p < 0.01).
- Bioavailability returned to baseline levels by 24 hours post-surgery.
- Indicates impaired oral drug absorption in the early postoperative period.
Conclusions:
- Oral medication should be administered judiciously within the first 12 hours following laparoscopic surgery.
- Findings provide critical insights for optimizing postoperative pain management and medication regimens.
- Further research may explore alternative routes of administration or modified dosing strategies.
Related Concept Videos
01:13Bioavailability: Overview
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
01:23Factors Influencing Bioavailability: First-Pass Elimination
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
01:26Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
01:20Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
01:17Bioavailability: Overview
Bioavailability refers to the proportion of an administered drug that reaches the systemic circulation in its active, unaltered form. It is a crucial pharmacokinetic parameter that determines the effectiveness of a drug in achieving its intended therapeutic outcomes. The route of administration significantly influences bioavailability, with intravenous administration achieving 100% bioavailability as the drug directly enters the bloodstream. In contrast, oral administration often results in...
01:30Modified-Release Drug Delivery Systems: Bioavailability
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...